Associations Between Tobacco and Cannabis Use and Anxiety and Depression Among Adults in the United States: Findings from the COVID-19 Citizen Science Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2023 Sep 13

PMID 37703257

Authors

Nhung Nguyen

Noah D Peyser

Jeffrey E Olgin

Mark J Pletcher

Alexis L Beatty

Madelaine F Modrow

Thomas W Carton

Rasha Khatib

Djeneba Audrey Djibo

Pamela M Ling

Gregory M Marcus

Affiliations

Soon will be listed here.

Abstract

Background: Little is known about whether people who use both tobacco and cannabis (co-use) are more or less likely to have mental health disorders than single substance users or non-users. We aimed to examine associations between use of tobacco and/or cannabis with anxiety and depression.

Methods: We analyzed data from the COVID-19 Citizen Science Study, a digital cohort study, collected via online surveys during 2020-2022 from a convenience sample of 53,843 US adults (≥ 18 years old) nationwide. Past 30-day use of tobacco and cannabis was self-reported at baseline and categorized into four exclusive patterns: tobacco-only use, cannabis-only use, co-use of both substances, and non-use. Anxiety and depression were repeatedly measured in monthly surveys. To account for multiple assessments of mental health outcomes within a participant, we used Generalized Estimating Equations to examine associations between the patterns of tobacco and cannabis use with each outcome.

Results: In the total sample (mean age 51.0 years old, 67.9% female), 4.9% reported tobacco-only use, 6.9% cannabis-only use, 1.6% co-use, and 86.6% non-use. Proportions of reporting anxiety and depression were highest for the co-use group (26.5% and 28.3%, respectively) and lowest for the non-use group (10.6% and 11.2%, respectively). Compared to non-use, the adjusted odds of mental health disorders were highest for co-use (Anxiety: OR = 1.89, 95%CI = 1.64-2.18; Depression: OR = 1.77, 95%CI = 1.46-2.16), followed by cannabis-only use, and tobacco-only use. Compared to tobacco-only use, co-use (OR = 1.35, 95%CI = 1.08-1.69) and cannabis-only use (OR = 1.17, 95%CI = 1.00-1.37) were associated with higher adjusted odds for anxiety, but not for depression. Daily use (vs. non-daily use) of cigarettes, e-cigarettes, and cannabis were associated with higher adjusted odds for anxiety and depression.

Conclusions: Use of tobacco and/or cannabis, particularly co-use of both substances, were associated with poor mental health. Integrating mental health support with tobacco and cannabis cessation may address this co-morbidity.

Citing Articles

Vaping nicotine and cannabis on the same occasion is linked to increased vaping consumption among young adults: A smartphone-based daily diary study.

Nguyen N, Keyhani S, Marcus G, Do V, Halliday D, Herbst E Drug Alcohol Depend. 2024; 266:112517.

PMID: 39644839 PMC: 11685029. DOI: 10.1016/j.drugalcdep.2024.112517.

Factors Associated with Older People's Anxiety Symptom Positioning after COVID-19: Cross-Sectional Findings from a Canadian Sample.

Low G, AliSher A, Morero J, Gao Z, Gutman G, Franca A Healthcare (Basel). 2024; 12(18).

PMID: 39337177 PMC: 11431020. DOI: 10.3390/healthcare12181837.

Trends in cannabis and tobacco co-use in the United States, 2002-2021.

Rubenstein D, McClernon F, Pacek L Addict Behav. 2024; 158:108129.

PMID: 39154418 PMC: 11471026. DOI: 10.1016/j.addbeh.2024.108129.

Tobacco-cannabis co-use among cancer patients and survivors: findings from 2 US cancer centers.

Smith D, Kaye J, Walters K, Schlienz N, Hyland A, Ashare R J Natl Cancer Inst Monogr. 2024; 2024(66):234-243.

PMID: 39108242 PMC: 11303862. DOI: 10.1093/jncimonographs/lgad035.

Urgent need for treatment addressing co-use of tobacco and cannabis: An updated review and considerations for future interventions.

Nguyen N, Bold K, McClure E Addict Behav. 2024; 158:108118.

PMID: 39089194 PMC: 11365784. DOI: 10.1016/j.addbeh.2024.108118.

References

Onaemo V, Fawehinmi T, DArcy C . Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys. J Affect Disord. 2020; 281:467-475. DOI: 10.1016/j.jad.2020.12.043. View

Cohn A, Chen S . Age groups differences in the prevalence and popularity of individual tobacco product use in young adult and adult marijuana and tobacco co-users and tobacco-only users: Findings from Wave 4 of the population assessment of tobacco and health study. Drug Alcohol Depend. 2022; 233():109278. PMC: 9028208. DOI: 10.1016/j.drugalcdep.2022.109278. View

Peters E, Schwartz R, Wang S, OGrady K, Blanco C . Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence. Drug Alcohol Depend. 2013; 134:228-234. PMC: 3865597. DOI: 10.1016/j.drugalcdep.2013.10.003. View

Prochaska J, Das S, Young-Wolff K . Smoking, Mental Illness, and Public Health. Annu Rev Public Health. 2016; 38:165-185. PMC: 5788573. DOI: 10.1146/annurev-publhealth-031816-044618. View

Driezen P, Gravely S, Wadsworth E, Smith D, Loewen R, Hammond D . Increasing Cannabis Use Is Associated With Poorer Cigarette Smoking Cessation Outcomes: Findings From the ITC Four Country Smoking and Vaping Surveys, 2016-2018. Nicotine Tob Res. 2021; 24(1):53-59. PMC: 8666121. DOI: 10.1093/ntr/ntab122. View

Cougle J, Hakes J, Macatee R, Chavarria J, Zvolensky M . Quality of life and risk of psychiatric disorders among regular users of alcohol, nicotine, and cannabis: An analysis of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). J Psychiatr Res. 2015; 66-67:135-41. DOI: 10.1016/j.jpsychires.2015.05.004. View

Zeger S, Liang K, Albert P . Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988; 44(4):1049-60. View

Adler N, Epel E, Castellazzo G, Ickovics J . Relationship of subjective and objective social status with psychological and physiological functioning: preliminary data in healthy white women. Health Psychol. 2000; 19(6):586-92. DOI: 10.1037//0278-6133.19.6.586. View

Pacek L, Weinberger A, Zhu J, Goodwin R . Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions. Addiction. 2019; 115(5):935-943. PMC: 7156311. DOI: 10.1111/add.14883. View

10.

Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J . Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2019; 76(4):426-434. PMC: 6450286. DOI: 10.1001/jamapsychiatry.2018.4500. View

11.

Carlini B, Schauer G . Cannabis-only use in the USA: prevalence, demographics, use patterns, and health indicators. J Cannabis Res. 2022; 4(1):39. PMC: 9306107. DOI: 10.1186/s42238-022-00143-y. View

12.

Weinberger A, Wyka K, Goodwin R . Impact of cannabis legalization in the United States on trends in cannabis use and daily cannabis use among individuals who smoke cigarettes. Drug Alcohol Depend. 2022; 238:109563. DOI: 10.1016/j.drugalcdep.2022.109563. View

13.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

14.

Ettman C, Abdalla S, Cohen G, Sampson L, Vivier P, Galea S . Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2020; 3(9):e2019686. PMC: 7489837. DOI: 10.1001/jamanetworkopen.2020.19686. View

15.

McRobbie H, Boland V, Courtney R . Assessing cannabis and tobacco co-use: the pros and cons of additional data collection. Addiction. 2021; 116(7):1631-1633. DOI: 10.1111/add.15373. View

16.

Hindocha C, McClure E . Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it. Addiction. 2020; 116(7):1622-1630. PMC: 8041912. DOI: 10.1111/add.15290. View

17.

Hindocha C, Brose L, Walsh H, Cheeseman H . Cannabis use and co-use in tobacco smokers and non-smokers: prevalence and associations with mental health in a cross-sectional, nationally representative sample of adults in Great Britain, 2020. Addiction. 2020; 116(8):2209-2219. DOI: 10.1111/add.15381. View

18.

Rabin R, George T . A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use. Am J Addict. 2015; 24(2):105-116. DOI: 10.1111/ajad.12186. View

19.

van der Meer R, Willemsen M, Smit F, Cuijpers P . Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013; (8):CD006102. DOI: 10.1002/14651858.CD006102.pub2. View

20.

Ream G, Benoit E, Johnson B, Dunlap E . Smoking tobacco along with marijuana increases symptoms of cannabis dependence. Drug Alcohol Depend. 2008; 95(3):199-208. PMC: 2440496. DOI: 10.1016/j.drugalcdep.2008.01.011. View